Why Use Over the Border Meds
Candidates include survodutide, which, like tirzepatide, targets both GLP-1 and glucagon and could help treat fatty liver disease, and retatrutide, under study by Eli Lilly, which acts on three gastrointestinal hormone receptors
Fernando Gallardo has received fees as presenter, consultant, and support for attendance of course and congresses and/or investigation projects in the following companies: Janssen, Abbvie, UCB, Amgen, Bristol, Lilly, Novartis, Almirall, Leo Pharma
GLP-1 receptor agonists exert their beneficial effects on the liver through multiple interconnected mechanisms, both direct and indirect
10.1016/j.peptides.2017.11.016 13